Healthcare Realty Trust Incorporated (HR) Market Cap

Healthcare Realty Trust Incorporated (HR) has a market capitalization of $6.43B, based on the latest available market data.

Financials updated after earnings reported 2025-12-31.

Sector: Real Estate
Industry: REIT - Healthcare Facilities
Employees: 550
Exchange: New York Stock Exchange
Headquarters: Nashville, TN, US
Website: https://www.healthcarerealty.com

Loading company profile...

Expand full investment commentary β–Ό

πŸ“˜ HEALTHCARE REALTY TRUST INC CLASS (HR) β€” Investment Overview

🧩 Business Model Overview

Healthcare Realty Trust Inc. (HR) is a self-managed real estate investment trust (REIT) focused primarily on owning, managing, acquiring, and developing outpatient medical facilities across the United States. The company’s strategic emphasis lies in properties associated with leading hospital systems, physician groups, and other key outpatient operators. HR operates under a pure-play model within the medical office sector, primarily targeting Class A facilities located on or adjacent to hospital campuses in large and mid-sized metropolitan areas. The trust’s operational approach centers on long-term leasing arrangements with healthcare providers, emphasizing stability and predictability of rental income. HR maintains an internal property management and leasing platform to ensure high service standards and tenant retention. Capital allocation priorities are disciplined, balancing prudent acquisitions, selective developments, and portfolio optimization. As a REIT, Healthcare Realty Trust distributes a substantial portion of earnings to shareholders, adhering to the favorable tax treatment mandated by its structure.

πŸ’° Revenue Streams & Monetisation Model

Healthcare Realty Trust generates revenue primarily from rental income derived from leasing its portfolio of medical office buildings (MOBs) and outpatient facilities to healthcare tenants. Its rental agreements are often structured as triple-net or modified gross leases, where tenants bear responsibility for property taxes, insurance, and maintenance, thus reducing operating expense exposure for the company. Additional revenue streams include management fees, parking income, tenant improvement reimbursements, and ancillary services offered to tenants. The company may also recognize gains on asset sales or joint venture transactions as part of portfolio recycling initiatives. Escalation clauses in lease agreements, along with annual rent adjustments, provide consistent, inflation-linked growth to underlying cash flows.

🧠 Competitive Advantages & Market Positioning

Healthcare Realty Trust Inc. benefits from several durable competitive advantages within the medical office real estate sector: - **Strategic Portfolio Location**: HR focuses on acquiring and managing properties that are on or adjacent to hospital campuses, often in partnership with dominant regional health systems. Such proximity enhances tenant desirability and ensures higher occupancy and renewal rates. - **Relationship-Based Leasing**: Longstanding relationships with leading hospital systems and physician groups underpin tenant retention, contributing to stable cash flows and minimizing vacancy risk. - **Specialized Operational Expertise**: The company maintains in-house property management and leasing teams experienced in handling the unique requirements of healthcare tenants, ensuring superior service and compliance with healthcare regulations. - **High-Quality Portfolio**: The asset base largely comprises Class A properties with modern infrastructure, fostering resilience to obsolescence and aligning with providers’ stringent location and facility requirements. - **Fragmented Market Dynamics**: The medical office sub-sector remains fragmented and under-institutionalized compared to other commercial real estate sectors, providing HR ongoing opportunities for accretive acquisitions and consolidations. Taken together, these factors underpin Healthcare Realty Trust’s market leadership in the medical office building sector, particularly in prime urban and suburban markets.

πŸš€ Multi-Year Growth Drivers

Several structural and cyclical trends provide long-term support for Healthcare Realty Trust’s growth outlook: - **Demographic Tailwinds**: An aging U.S. population is driving sustained increases in demand for outpatient healthcare services, bolstering space needs for medical office tenants. - **Shift to Outpatient Care**: Healthcare delivery is transitioning from acute inpatient settings to lower-cost, outpatient environments. This migration underscores the growing importance of medical office buildings and outpatient facilities. - **Tenant Credit Quality**: Expanding partnerships with investment-grade hospital systems and leading physician groups secures high-credit tenants, improves portfolio resilience, and supports premium rental rates. - **Development and Acquisition Pipeline**: HR is well-positioned to capitalize on selective development opportunities and acquisitions in targeted regions, driven by prudent capital allocation and a focus on strategic synergy with healthcare trends. - **Market Fragmentation**: The large pool of non-institutionally owned medical office assets creates a broad opportunity set for future consolidation, enabling HR to expand geographically and diversify its tenant base. - **Technological Adoption**: Increasing integration of telehealth and digital health requires modernized spaces, favoring facility upgrades and the construction of state-of-the-art properties.

⚠ Risk Factors to Monitor

Investors should remain attentive to several material risk factors: - **Regulatory and Reimbursement Risk**: Changes in healthcare policy, reimbursement rates, or government funding can impact tenant profitability, potentially affecting rental income stability. - **Tenant Concentration**: Significant exposure to major health systems or physician groups introduces credit risk should a key tenant renegotiate or default. - **Interest Rate Volatility**: As a REIT with substantial dividend obligations, HR’s cost of capital and property valuations are sensitive to changes in interest rates. - **Development and Acquisition Execution**: Delays, cost overruns, or integration risks associated with new developments and portfolio acquisitions may impact returns. - **Market Competition**: The growing institutional interest in healthcare real estate increases competition for high-quality assets, potentially compressing acquisition yields. - **Macroeconomic and Health Event Risks**: Economic downturns, pandemics, or shifts in demand for outpatient services can affect occupancy rates, collection of rental income, and asset values.

πŸ“Š Valuation & Market View

Healthcare Realty Trust is typically valued using a blend of methods, primarily including funds-from-operations (FFO) multiples and net asset value (NAV) calculations, in line with broader REIT sector norms. The company’s focus on high-quality, on-campus medical office buildings often commands a valuation premium relative to peers with less hospital system adjacency or lower asset quality. Market participants generally attribute a defensive, lower-volatility profile to HR’s cash flows given the demographically anchored demand and long-term leases characteristic of its tenant base. Dividend yield forms a key element of total return expectations for HR shareholders, underpinned by disciplined payout ratios and steady underlying property income streams. Valuation sensitivity to interest rate movements is a consideration, as rising rates may impact both income expectations and relative valuation multiples compared to other yield-oriented assets. Key valuation drivers include the pace of lease-up in new developments, success in accretive acquisitions, effective management of operating expenses, and ongoing maintenance of high tenant occupancy and retention levels.

πŸ” Investment Takeaway

Healthcare Realty Trust Inc. provides investors with targeted exposure to a vital and defensive niche within the commercial real estate universeβ€”medical office buildings and outpatient facilities. The company’s strategy of aligning with strong regional health systems, maintaining a high-quality asset base, and focusing on long-term, relationship-driven leasing has positioned HR as a leader in its segment. Demographics, the shift to outpatient care, and ongoing consolidation in the sector serve as enduring growth catalysts, while specialized operational execution and a disciplined capital allocation policy support stability. However, investors must carefully monitor policy shifts, interest rate dynamics, and potential disruptions from changing healthcare delivery patterns. Overall, HR offers a combination of consistent income generation, long-term growth prospects, and defensive characteristics suited to volatility-averse, income-focused portfolios seeking exposure to healthcare real estate.

⚠ AI-generated β€” informational only. Validate using filings before investing.

πŸ“’ Show latest earnings summary

HR Q4 2025 Earnings Summary

Overall summary: HR delivered a stronger-than-expected 2025 with robust same-store NOI growth, meaningful deleveraging, and successful portfolio pruning, while revamping its operating platform and strengthening governance. Management projects flat headline FFO in 2026 but highlights ~5% underlying core growth as dilution from 2025 dispositions and deleveraging rolls off. The outlook is supported by strong outpatient fundamentals, deepening health system relationships, and internally funded redevelopments, balanced by a higher bond refi coupon and a disciplined posture on external growth.

Growth

  • FY25 same-store cash NOI growth 4.8%; Q4 same-store cash NOI growth 5.5%
  • Executed ~5.8M sq ft of leases in 2025, including 1.6M sq ft of new leases
  • Portfolio escalators on 2025 leasing averaged 3.1%, lifting portfolio average to 2.9%
  • Same-store absorption of ~290k sq ft in 2025, driving >100 bps occupancy gain
  • Under revamped platform, cash leasing spreads improved by 60 bps and tenant retention by 220 bps
  • Redevelopment lease percentage up 1,000 bps since Q3 on strong demand
  • 2026 guidance: same-store cash NOI growth of 3.5%–4.5%; embedded ~5% core earnings growth

Business development

  • Hartford HealthCare: 65k sq ft in CT backfilled Prospect Medical; retained full $3M of NOI; relationship now ~250k sq ft across 15 buildings (94% occupied)
  • Baptist (Memphis): extended 15 leases totaling ~170k sq ft for 8 years; added 3 new leases totaling 25k sq ft (10-year blended term); portfolio 99% leased
  • Tufts Medicine (Boston): 154k sq ft, 8-year early renewal (originally expiring 2027)
  • Advocate Health (Charlotte): three lease extensions totaling 142k sq ft (avg 7 years) with cash leasing spread >5%
  • Medical University of South Carolina (Charleston): 39k sq ft renewal (was expiring late 2026)
  • Over half of 1.4M sq ft of 2026–2027 single-tenant expirations already renewed or in documentation

Financials

  • Q4 normalized FFO/share: $0.40; FY25: $1.61 (beat original midpoint by $0.03)
  • Q4 FAD/share: $0.32; FY25 FAD/share: $1.26
  • Q4 dividend payout ratio: ~75%
  • G&A run-rate savings achieved: $10M; total G&A now ~$45M
  • Property NOI margins improved by 60 bps
  • Weighted average lease term nearly 6 years; tenant retention 82% in 2025

Capital & funding

  • Completed $1.2B of asset sales in 2025 at a blended 6.7% cap rate; exited 14 noncore markets
  • Q4 dispositions ~ $700M; total debt repaid in 2025 ~$900M (including a bond repayment)
  • Net debt/EBITDA reduced to ~5.4x from 6.4x; debt maturities extended 12–24 months
  • Credit outlooks improved to Stable at both Moody’s and S&P
  • Dividend rightsized; well covered; ~6% current yield (management commentary)
  • January 2026: repurchased $50M of stock (~2.9M shares); $450M remains under authorization
  • 2026 sources: modest asset sales, note receivable proceeds (early 2026), and ~$100M post-dividend FCF (midpoint)
  • 2026 uses: asset-level capital plan and the $50M buyback already executed; guidance excludes additional acquisitions, developments, or further repurchases
  • Assumes refinancing of $600M bond due Aug-2026 at a low-5% coupon vs existing 3.5%
  • Launched a $600M commercial paper program to diversify funding and lower interest costs vs revolver

Operations & strategy

  • Revamped asset management platform completed; tighter alignment with leasing and ROI discipline
  • New leasing model emphasizing economic returns; driving higher spreads, retention, and lease IRRs
  • Focus on redevelopments within existing portfolio targeting ~10% yields on cost
  • Improved operating rigor and tenant satisfaction; emphasis on health system relationships
  • Geographic footprint sharpened toward high-growth MSAs after exiting noncore markets
  • Governance enhancements: board streamlined to seven; new CFO appointed

Market & outlook

  • Outpatient demand strong; supply and completions near all-time lows relative to inventory
  • Health systems continue robust investment in outpatient services; dialogue at all-time high
  • 2026 normalized FFO guidance: $1.58–$1.64 (midpoint $1.61; flat YoY headline but ~5% core growth expected)
  • Expected 2026 same-store growth largely driven by escalators (~75%+ of SSS growth), with retention trending mid-80s and continued positive leasing spreads
  • Leverage expected to remain in the mid-5x net debt/EBITDA range

Risks & headwinds

  • Higher refinancing costs: 2026 bond expected to reprice from 3.5% to low-5% coupon
  • Limited external growth given current cost of capital and discount to intrinsic asset value
  • 2026 same-store NOI growth guided below 2025’s level as prior-year absorption tailwind normalizes
  • Guidance excludes acquisitions, new developments, or additional repurchases, limiting upside in base case
  • Leverage may fluctuate modestly quarter to quarter

Sentiment: positive

πŸ“Š Healthcare Realty Trust Incorporated (HR) β€” AI Scoring Summary

πŸ“Š AI Stock Rating β€” Summary

Healthcare Realty Trust Incorporated reported a quarterly revenue of $286.30 million and net income of $14.39 million, yielding an EPS of $0.0398 and a solid net margin of 5.03%. Free cash flow stood at $45.79 million, signaling a healthy cash generation position. Year-over-year growth and valuation context indicate focus areas for strategic assessment. Revenue growth appears stable but modest, guided mainly by consistent leasing activities and portfolio management. Despite a relatively low EPS, profitability metrics remain resilient, supported by positive net income and efficient cost structures. Free cash flow, however, fell short of covering significant debt repayment activities, reflecting on operational cash flow reliance. The balance sheet indicates a moderate leverage with net debt at $4.12 billion against total equity of $4.68 billion, highlighting a managed leverage position. Dividend payouts remain robust, with a $0.24 per share recently, aligning with stable cash returns to shareholders. Valuation metrics and analyst price targeting suggest conservatively optimistic sentiment, with a price range targeting between $19 and $21 and consensus around $19.67, reflecting measured market expectations.

AI Score Breakdown

Revenue Growth β€” Score: 6/10

Revenue grew modestly, with stable leasing driving main growth, suggesting consistency but limited acceleration.

Profitability β€” Score: 7/10

Reasonable net margins at 5.03%, though EPS is low; cost management supports profitability.

Cash Flow Quality β€” Score: 7/10

Strong free cash flow generation of $45.79 million; covers dividends but heavy debt repayments challenge liquidity.

Leverage & Balance Sheet β€” Score: 6/10

Leverage is moderate, net debt at $4.12 billion against $4.68 billion of equity, indicating a manageable debt position.

Shareholder Returns β€” Score: 8/10

Consistent quarterly dividends and a history of stable shareholder distributions enhance investor value.

Analyst Sentiment & Valuation β€” Score: 7/10

Analyst sentiment is cautiously positive with a modest price target range, indicating fair market perceptions.

⚠ AI-generated β€” informational only, not financial advice.

SEC Filings